MicroRNA-106a Provides Negative Feedback Regulation in Lipopolysaccharide-Induced Inflammation by targeting TLR4

Area of Science:

• Molecular Biology
• Immunology
• Respiratory Medicine

Background:

• Acute lung injury (ALI) is a critical condition with high mortality, marked by severe inflammation and tissue damage.
• MicroRNAs (miRNAs) are recognized as key regulators of inflammatory processes in various diseases.
• The specific role of miR-106a in lipopolysaccharide (LPS)-induced ALI remains largely unexplored.

Purpose of the Study:

• To investigate the role and mechanism of miR-106a in LPS-induced acute lung injury.
• To determine if miR-106a influences the production of pro-inflammatory cytokines in ALI.
• To elucidate the signaling pathway through which miR-106a exerts its effects in ALI.

Main Methods:

• Quantitative real-time PCR to measure miR-106a expression in ALI mouse models and LPS-stimulated macrophages.
• Overexpression and inhibition of miR-106a in cellular and animal models of ALI.
• Measurement of pro-inflammatory cytokines (IL-1β, IL-6, TNF-α) and assessment of NF-κB activation.
• Luciferase reporter assays to confirm direct binding of miR-106a to the 3'-UTR of TLR4.

Main Results:

• miR-106a expression was significantly downregulated in lung tissues of ALI mice and LPS-treated macrophages.
• Overexpression of miR-106a reduced pro-inflammatory cytokine production and NF-κB activation.
• miR-106a directly targets TLR4, inhibiting its expression and subsequently suppressing the TLR4/NF-κB signaling pathway.
• Inhibition of miR-106a reversed these anti-inflammatory effects.

Conclusions:

• miR-106a functions as a negative feedback regulator in LPS-induced inflammation.
• The miR-106a/TLR4/NF-κB axis represents a potential therapeutic target for managing acute lung injury.
• These findings highlight the critical role of miR-106a in modulating inflammatory responses within the context of ALI.